行情

HTGM

HTGM

HTG Molecular
NASDAQ

实时行情|Nasdaq Last Sale

0.5826
-0.0340
-5.51%
盘后: 0.5826 0 0.00% 16:58 01/27 EST
开盘
0.6202
昨收
0.6166
最高
0.6202
最低
0.5500
成交量
98.46万
成交额
--
52周最高
3.240
52周最低
0.5586
市值
3,380.90万
市盈率(TTM)
-1.0029
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

HTGM 新闻

  • HTG Molecular Diagnostics Narrows FY2019 Sales Guidance from $19M-20M to $19.2M
  • Benzinga.01/13 13:20
  • HTG Molecular Diagnostics Announces Preliminary 2019 Unaudited Financial Results
  • GlobeNewswire.01/13 13:00
  • Investors Who Bought HTG Molecular Diagnostics (NASDAQ:HTGM) Shares A Year Ago Are Now Down 68%
  • Simply Wall St..01/13 12:55
  • 沪指重返3100点 在岸人民币对美元升破6.90关口
  • 新浪财经.01/13 09:30

更多

所属板块

先进医疗设备和技术
-1.95%
医疗设备和用品
-1.02%

热门股票

名称
价格
涨跌幅

HTGM 简况

HTG Molecular Diagnostics, Inc. is a commercial-stage company that develops and markets a technology platform to facilitate the routine use of complex molecular profiling. The Company's HTG Edge and HTG EdgeSeq platforms, consisting of instrumentation, consumables and software analytics, are used in sample profiling applications, including tumor profiling, molecular diagnostic testing and biomarker development. The Company's HTG Edge and HTG EdgeSeq platforms automate the molecular profiling of genes and gene activity using its nuclease protection chemistry on a range of biological samples. The Company's HTG EdgeSeq chemistry, together with its HTG Edge or HTG EdgeSeq instrumentation and software, automates and adapts its nuclease protection chemistry to enable analysis using next generation sequencing (NGS) instrumentation. The HTG EdgeSeq system utilizes substantially the same sample preparation reagents as its original chemistry, but allows for read out on an NGS instrument.
展开

Webull提供HTG Molecular Diagnostics Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。